Welcome to our dedicated page for Marsh & Mclennan news (Ticker: MMC), a resource for investors and traders seeking the latest updates and insights on Marsh & Mclennan stock.
Marsh & McLennan Companies, Inc. reports developments across risk, reinsurance and capital advisory, people and investment consulting, and management consulting. Company updates often center on Marsh Risk and its digital risk analytics tools, Mercer workforce, compensation, health and retirement advisory alliances, Oliver Wyman consulting operations, and Marsh McLennan Agency insurance, benefits, retirement and wealth solutions in the U.S. and Canada.
Recurring news also covers quarterly operating results, enterprise partnerships, AI-enabled service delivery, leadership and governance changes, material agreements, and capital-structure matters tied to the company's common stock and debt financing.
Mitsubishi Electric Corporation (TOKYO: 6503) has signed an agreement to transfer shares of its insurance subsidiary, Mitsubishi Electric Insurance Service Co., Ltd., to Marsh Japan, Inc., a subsidiary of Marsh McLennan (NYSE: MMC). The transaction is scheduled to complete on November 4, 2025.
Mitsubishi Electric Insurance Service, established in 1999, has been operating as an insurance agency for the Mitsubishi Electric Group. The decision comes after Mitsubishi Electric's strategic assessment of its insurance business portfolio and consideration of the evolving Japanese insurance agency landscape. The company believes partnering with Marsh Japan, which brings Marsh LLC's global insurance expertise, will better position the subsidiary for long-term growth.
The financial impact of this transaction is expected to be minimal and is not included in Mitsubishi Electric's fiscal year 2026 forecast.
Corridor Platforms, in collaboration with Oliver Wyman (NYSE:MMC) and Google Cloud, has announced the launch of a Responsible AI Sandbox to help enterprises scale their GenAI deployments safely. The initiative, launching in August 2025, follows the successful release of GenGuardX, Corridor's GenAI governance platform.
The Sandbox will be hosted on Google Cloud's infrastructure and will initially focus on Conversational AI use cases for U.S. financial institutions. Key features include an end-to-end GenAI pipeline, interactive risk labs, configurable risk modeling, expert-led guidance, and external agent risk assessment capabilities. The platform will integrate with Google Cloud's AI platform Vertex AI and Gemini language models, while allowing participants to use their own tools and LLMs.
Marsh McLennan (NYSE: MMC) reported strong Q2 2025 financial results, with revenue reaching $7.0 billion, up 12% year-over-year (4% underlying growth). The company achieved $1.8 billion in operating income, an 11% increase, while adjusted operating income rose 14% to $2.1 billion.
Key performance metrics include GAAP EPS of $2.45 (8% increase) and adjusted EPS of $2.72 (11% increase). The Risk & Insurance Services segment saw 15% revenue growth to $4.6 billion, while Consulting revenue increased 7% to $2.4 billion. The company also announced a 10% dividend increase to $0.900 per share and repurchased 1.4 million shares for $300 million during Q2.
Mercer (NYSE: MMC) has released its Survey on Health and Benefit Strategies for 2026, revealing significant changes in employer health benefit strategies. The survey indicates that 51% of large employers (500+ employees) are likely to shift more healthcare costs to employees in 2026, up from 45% last year, as health benefit costs are projected to grow by nearly 6%.
Key findings include: 35% of large employers plan to offer non-traditional medical plans, 44% currently cover GLP-1 drugs for obesity treatment, and 77% consider managing weight-loss medication costs a top priority. Additionally, 75% of large employers will offer digital stress management resources, while 40% will provide mental health training for managers.
Marsh McLennan (NYSE: MMC) has appointed Bruce Broussard to its Board of Directors, effective immediately, expanding the board to 12 directors. Broussard brings over 30 years of healthcare leadership experience, having served as CEO of Humana from 2013 to 2024 and previously as CEO of McKesson Specialty/US Oncology.
The appointment strengthens MMC's board with Broussard's extensive insurance and healthcare sector expertise, along with his experience as both a CEO and CFO. He currently serves on the boards of HP Inc., Cleveland Clinic, and One Call, while holding leadership positions in various advocacy organizations.
Marsh McLennan (NYSE: MMC) announced a 10% increase in its quarterly dividend. The new dividend of $0.900 per share, up from $0.815, will be paid on August 15, 2025 to shareholders of record as of July 24, 2025.
This dividend increase demonstrates the company's commitment to returning value to shareholders and reflects confidence in its financial stability.
Marsh McLennan Agency (NYSE:MMC), a leading insurance solutions provider, has announced the acquisition of Excel Insurance, a Florida-based independent agency specializing in property/casualty insurance for small businesses and individuals.
Excel Insurance, founded in 2020, brings expertise in watercraft and motor vehicle protection to MMA's portfolio. The acquisition will integrate all Excel employees, including President Jacob Pared, into MMA's existing Doral office, strengthening MMA's presence in South Florida. The financial terms of the acquisition were not disclosed.
Marsh McLennan (NYSE: MMC) has announced that its consulting business Oliver Wyman will acquire Validate Health, a healthcare analytics company. The acquisition, set to close in summer 2025, will integrate Validate Health into Oliver Wyman Actuarial, enhancing their capabilities in healthcare analytics and actuarial services.
The strategic acquisition combines Oliver Wyman's actuarial expertise with Validate Health's data-driven solutions, strengthening their ability to help healthcare providers and ACOs manage costs, risk, and performance. The integration aims to improve healthcare delivery efficiency and enhance patient outcomes through advanced analytics platforms.
Marsh McLennan (NYSE: MMC) held its 2025 Annual Meeting of Stockholders where shareholders approved several key measures. The meeting resulted in the re-election of 11 directors to serve one-year terms, including John Q. Doyle, the company's President and CEO. Notable board changes include the retirement of Oscar Fanjul after more than 23 years of service.
Stockholders also approved three additional measures: the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2025, a non-binding approval of executive officer compensation, and the approval of the Company's Amended and Restated 2020 Incentive and Stock Award Plan.